EPISODE · Feb 2, 2026 · 1 MIN
Novel Drug May Help Adults with Obesity Lose Up to 22.5% Weight
from TheBrief.Health · host TheBrief.Health
CT-388, a dual GLP-1/GIP agonist, demonstrated over 22% weight loss at 48 weeks, offering a promising new treatment option for adults with obesity.
What this episode covers
CT-388, a dual GLP-1/GIP agonist, demonstrated over 22% weight loss at 48 weeks, offering a promising new treatment option for adults with obesity.
NOW PLAYING
Novel Drug May Help Adults with Obesity Lose Up to 22.5% Weight
No transcript for this episode yet
Similar Episodes
Apr 21, 2026 ·13m
Apr 19, 2026 ·16m
Apr 17, 2026 ·13m
Apr 13, 2026 ·11m
Apr 11, 2026 ·16m